Captomer [succinic acid — Class II drug recall D-1383-2014
Terminated recall by Thorne Research Inc, reported 2014-06-25, distributed nationwide. Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and label
| Recall number | D-1383-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Thorne Research Inc, Sandpoint, ID, United States |
| Recall initiated | 2014-06-12 |
| Classified | 2014-06-13 |
| Reported by FDA | 2014-06-25 |
| Terminated | 2014-10-15 |
| Distributed | Nationwide (US) |
| Countries outside the US | EG, GB, NZ, SE, UA |
| Reason classes | labeling, unapproved product |
| UPC / GTIN / UDI-DI | 00693749740025 |
Product
Captomer [succinic acid (from 100 mg DMSA)] capsules, 65 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 74002 5
Reason for recall
Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1383-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.